This article is more than 5 years old. Information may no longer be current.
Top stories in hematology/oncology: FDA grants fast track designation for diffuse large B-cell lymphoma treatment, virtual platform offers support for patients with cancer
Click Here to Manage Email Alerts
Among the top stories in hematology/oncology last week were the FDA granting fast track designation to CLR 131 for the treatment of diffuse large B-cell lymphoma and a Q&A focusing on a virtual program that provides nutritional and wellness support for patients with cancer.
Other highlights included the FDA granting orphan drug designation to durvalumab for the treatment of small cell lung cancer, a Q&A about a study that found dentists are detecting a growing number of oral cancers and precursor lesions and research that suggested men with prostate cancer who underwent radical prostatectomy remained interested in sex despite functional losses and appeared able to salvage satisfaction.
FDA grants fast track designation to CLR 131 for diffuse large B-cell lymphoma
The FDA granted fast track designation to CLR 131 for treatment of relapsed or refractory diffuse large B-cell lymphoma. Read more.
Virtual platform offers nutritional, wellness support for patients with cancer
Virtual Health Partners recently launched a virtual program to provide nutritional and wellness support for patients with cancer. Read more.
FDA grants orphan drug designation to Imfinzi for small cell lung cancer
The FDA granted orphan drug designation to durvalumab for the treatment of small cell lung cancer. Read more.
Dentists detect growing number of oral cancers, precursor lesions
The number of oral cancers and precursor lesions detected by dentists in Ontario increased sharply over a 10-year period, according to study results. Read more.
Men retain sexual interest, salvage satisfaction after radical prostatectomy
Men with prostate cancer who underwent radical prostatectomy remained interested in sex despite functional losses and appeared able to salvage satisfaction, according to results of a retrospective study based on the recently developed Patient-Reported Outcome Measurement Information System. Read more.